TY - JOUR
T1 - Letrozole and norethisterone acetate in rectovaginal endometriosis
AU - Remorgida, Valentino
AU - Abbamonte, Helena Luiza
AU - Ragni, Nicola
AU - Fulcheri, Ezio
AU - Ferrero, Simone
PY - 2007/9
Y1 - 2007/9
N2 - This open-label prospective study evaluated the efficacy of letrozole (2.5 mg/day) combined with norethisterone acetate (2.5 mg/day) in the treatment of pain symptoms related to the presence of rectovaginal endometriosis. The treatment significantly and quickly decreased the intensity of symptoms, but pain recurred at 3-month follow-up; five women underwent surgery during the follow-up, and histologic examination of rectovaginal nodules revealed the presence of active endometriotic lesions.
AB - This open-label prospective study evaluated the efficacy of letrozole (2.5 mg/day) combined with norethisterone acetate (2.5 mg/day) in the treatment of pain symptoms related to the presence of rectovaginal endometriosis. The treatment significantly and quickly decreased the intensity of symptoms, but pain recurred at 3-month follow-up; five women underwent surgery during the follow-up, and histologic examination of rectovaginal nodules revealed the presence of active endometriotic lesions.
UR - http://www.scopus.com/inward/record.url?scp=34547793504&partnerID=8YFLogxK
U2 - 10.1016/j.fertnstert.2006.12.027
DO - 10.1016/j.fertnstert.2006.12.027
M3 - Article
SN - 0015-0282
VL - 88
SP - 724
EP - 726
JO - Fertility and Sterility
JF - Fertility and Sterility
IS - 3
ER -